Comparative Effects of Aerobic Exercises and Progressive Muscle Relaxation Exercises on Pain and Quality of Life
Comparative Effects of Aerobic Exercises and Progressive Muscle Relaxation Exercises on Pain,Anxiety and Quality of Life
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan
- Johar Institute of Professional Studies
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 18 to 40 years
- Females in their last week of the luteal phase (1 week before menstruation)
- Females with regular menstrual with equal intervals between 21 and 35 days
- Females with a score of 133 and above after being screened with Premenstrual syndrome scale
- Females suffering from PMS for at least the past six months
Exclusion Criteria:
- Females with the irregular menstrual cycle
- Pregnant females
- Menstruating females or females in the follicular or ovulatory phase
- History of physical exercise in the past three months before the beginning of the study
- Females suffering from other gynecological issues such as endometriosis, PCOS, uterine or cervical cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group A: aerobic exercises.
The first treatment group will be given aerobic exercises for six weeks at least three times per week.
This group will include 14 participants.
This study group will be assigned with basic treatment protocol with aerobic exercises along with 10 minutes of warm up period.
|
To compare the effects of aerobic exercise and progressive muscle relaxation exercises on pain and quality of life in premenstrual syndrome
|
|
Active Comparator: group b progressive muscle relaxation exercises.
The intervention will be given three days per week for six weeks. Pre and post-treatment readings will be noted. Each total session will last for 45 minutes. The importance of the study will be explained, and consent will be taken from the people before the intervention will be applied.
|
progressive muscle relaxation exercises.
|
|
No Intervention: Group C. Control group
No intervention was given
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1. For Anxiety, Depression: • DASS-21 The Depression, Anxiety and Stress Scale - 21 Items (DASS-21)
Time Frame: 6 weeks
|
The Depression, Anxiety and Stress Scale - 21 Items (DASS-21) is a set of three self-report scales designed to measure the emotional states of depression, anxiety and stress.(16)
|
6 weeks
|
|
Numerical rating scales (NRSs)
Time Frame: 6 weeks
|
Numerical rating scales (NRSs) are the simplest and most commonly used scale.
The numerical scale is most commonly 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable
|
6 weeks
|
|
• SF-36 The 36-Item Short Form Health Survey questionnaire (SF-36)
Time Frame: 6 weeks
|
The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life.
The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH)
|
6 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Fatima Tariq, Mphill, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- REC/RCR & AHS/22/054
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.